High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study.

MLA

Su, Yanhong, et al. “High-Dose Tamoxifen in High-Hormone-Receptor-Expressing Advanced Breast Cancer Patients: A Phase II Pilot Study.” Therapeutic Advances in Medical Oncology, Feb. 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1177/1758835921993436.

APA

Su, Y., Zhang, Y., Hua, X., Huang, J., Bi, X., Xia, W., Wang, X., Huang, Z., Song, C., Zhong, Y., Shi, Y., Wang, S., Fan, W., & Yuan, Z. (2021). High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study. Therapeutic Advances in Medical Oncology, 1–9. https://doi.org/10.1177/1758835921993436

Chicago

Su, Yanhong, Yarui Zhang, Xin Hua, Jiajia Huang, Xiwen Bi, Wen Xia, Xinyue Wang, et al. 2021. “High-Dose Tamoxifen in High-Hormone-Receptor-Expressing Advanced Breast Cancer Patients: A Phase II Pilot Study.” Therapeutic Advances in Medical Oncology, February, 1–9. doi:10.1177/1758835921993436.